Funded Grants

PI Name	PI Organization	Title	Grant Number	Initiative	Program Official Sort descending
Hu, Shuiying	Ohio State University United States	Prevention of paclitaxel-induced peripheral neuropathy with nilotinib	5R01CA238946-05		Rachel Altshuler, Ph.D.
Brown, Austin L	Baylor College Of Medicine United States	A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia	5R01CA272981-02		Rachel Altshuler, Ph.D.
Paus, Ralf	University Of Miami School Of Medicine United States	Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia	1R21CA277418-01A1		Rachel Altshuler, Ph.D.
Damaj, M. Imad	Virginia Commonwealth University United States	Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms	5R01CA272147-02	PAR-21-329 (R01 Clinical Trial Optional)	Rachel Altshuler, Ph.D.
Kroetz, Deanna L	Ohio State University United States	Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity	5R01CA261068-05		Rachel Altshuler, Ph.D.
Grueber, Wesley B	Columbia University Health Sciences United States	Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy	5R21CA274588-02		Rachel Altshuler, Ph.D.
Yennu, Sriram	University Of Tx Md Anderson Can Ctr United States	Opioid-Sparing Interdisciplinary Interventions Addressing Pain in Head and Neck Cancer Patients	5R21CA252446-02		Rachel Altshuler, Ph.D.
Tighiouart, Mourad	Cedars-Sinai Medical Center United States	Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials	3U01CA232859-05S1		Rachel Altshuler, Ph.D.
Albertson, Donna G	New York University United States	Artemin overexpression in oral cancer pain and carcinogenesis	5R01CA228525-05		Rachel Altshuler, Ph.D.
Spiegel, Brennan	Cedars-Sinai Medical Center United States	Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	5R01CA252211-04		Rachel Altshuler, Ph.D.